Researchers Aim to Create Point-of-Care Biosensor for Prostate Cancer
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read MorePosted by Steve Halasey | Oct 21, 2019 | Prostate |
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read MorePosted by Chaunie Brusie | Jun 30, 2019 | Point-of-Care |
The visually read tests deliver up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts against global epidemics.
Read MorePosted by Chaunie Brusie | Jun 21, 2019 | Research |
Research suggests that C-reactive protein tests should be performed by general practitioners for results within minutes, rather than being performed by central laboratories.
Read MorePosted by Chaunie Brusie | Apr 21, 2019 | Point-of-Care |
The test quantitatively measures total PSA from a fingerstick of whole blood analyzed on the company’s Claros 1 benchtop analyzer.
Read MorePosted by Steve Halasey | Dec 4, 2018 | Research |
Preliminary study findings suggest that a point-of-care test currently under development has accuracy similar to a high-sensitivity troponin test, permitting early rule-out of a heart attack.
Read More